n1.care extracts structured clinical data from uploaded medical records and generates AI-powered reports — each designed for a different clinical need.
n1.care turns unstructured medical documents into structured clinical intelligence — then generates AI-powered reports tailored to each patient.
Any medical PDF — lab results, clinical notes, imaging, genetics.
Biomarkers, diagnoses, procedures, and genetics — structured automatically.
Patterns identified, out-of-range values flagged, findings correlated.
Evidence-based insights, trend analysis, and clinical recommendations.
Every medical record is parsed into four structured data categories — forming the foundation for all reports and analysis.
Lab values, reference ranges, trends over time — standardised and enriched for longitudinal tracking.
Conditions identified from clinical records — coded, categorised, and tracked across time.
Imaging, surgeries, and clinical interventions — extracted and linked to patient timelines.
Genetic variants and pharmacogenomics — interpreted with clinical significance scoring.
Every patient is different. Every clinical question deserves a tailored approach. n1.care adapts to match your needs.
Comprehensive AI-powered health analysis with detailed clinical insights and evidence-based recommendations.
Visual and narrative representation of health data trends with interactive charts and analytics.
Multi-agent AI analysis providing diverse clinical perspectives on your health data.
LVEF at 65% is reassuring, but elevated D-Dimer (585 ng/mL) alongside a heart age of 53 warrants further investigation. Recommend coronary calcium scoring and lipid panel reassessment within 3 months.
Kidney function markers suggest early-stage filtration decline. The interplay between cardiovascular strain and renal perfusion should be monitored — CKD and CVD share accelerating risk factors.
Fasting insulin trending upward at 28.3 uIU/mL indicates developing insulin resistance. Combined with metabolic markers, early intervention through dietary changes and metformin consideration is advised.